Media Room Menu
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 11, 2008New post-hoc analysis from Athena Study showed that Multaq® on top of standard therapy significantly decreased the total number of hospital days by 28% in patients with atrial fibrillation or flutter
-
Oct 31, 2008
-
Oct 23, 2008Sanofi-aventis will comply with the European Authorities request to temporarily suspend the marketing authorisation of Acomplia® in obese and overweight patients and will make every effort to actively support patients and Health Care Professionals.